We Are Now on the PEI (Paul-Ehrlich-Institut ) Approval List!

Recently, the company's COVID-19 antigen rapid test (oral fluid) reagent successfully passed the performance evaluation of the German Federal Institute of Vaccines and Paul-Ehrlich-Institut (PEI). This not only means that the company's COVID-19 antigen rapid test (oral fluid) reagent has passed one of the most highly recognized and gold-containing tests in Europe, but it is also a reaffirmation of the quality of ALLTEST BIOTECH products, which provides confidence and support for the company's products to further open the international market.

The R&D team members of the COVID-19 antigen rapid test (oral fluid) product: Liu Cheng, Fu Yu, Xu Nuojuan, Kuang Lijuan, Zhang Hao, Zhang Qunyin, etc., eliminated all difficulties and successfully developed COVID-19 antigen rapid test (oral fluid) reagents for the company's development and growth. After the company's discussion, a commendation notice will be given to the above-mentioned employees.

The company calls on all employees to learn the above-mentioned spirit of hard work and active dedication, to create greater brilliance for the company, and to provide a steady stream of motivation for the company's growth.